What does Dr. Nathalie Schoofs, gastro-entérologie do?

Dr. Nathalie Schoofs, gastro-entérologie is a specialist medical practice in Jodoigne. Private Limited, started on 24 February 2009.

What is the address of Dr. Nathalie Schoofs, gastro-entérologie?

The registered office of Dr. Nathalie Schoofs, gastro-entérologie is located at Rue du Bey Defoer(Jod.) 16, 1370 Jodoigne.

Is Dr. Nathalie Schoofs, gastro-entérologie still active?

Yes. According to the CBE (18 September 2026) Dr. Nathalie Schoofs, gastro-entérologie is active, legal situation “Normale toestand”, started on 24 February 2009.

Is Dr. Nathalie Schoofs, gastro-entérologie registered on Peppol?

Yes, Dr. Nathalie Schoofs, gastro-entérologie is registered on the Peppol network with ID 0208:0810119551.

What is the enterprise number of Dr. Nathalie Schoofs, gastro-entérologie?

The enterprise number of Dr. Nathalie Schoofs, gastro-entérologie is BE0810119551.

When was Dr. Nathalie Schoofs, gastro-entérologie founded?

Dr. Nathalie Schoofs, gastro-entérologie was founded on 24 February 2009.

Who are the directors of Dr. Nathalie Schoofs, gastro-entérologie?

According to the 2024 annual accounts, the directors of Dr. Nathalie Schoofs, gastro-entérologie are: Nathalie Schoofs.

Is Dr. Nathalie Schoofs, gastro-entérologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 February 2009; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. Nathalie Schoofs, gastro-entérologie make in 2024?

Dr. Nathalie Schoofs, gastro-entérologie posted a profit after taxes of € 28,589 in financial year 2024.

What is the revenue of Dr. Nathalie Schoofs, gastro-entérologie?

As a small company, Dr. Nathalie Schoofs, gastro-entérologie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 76,402.

Dr. Nathalie Schoofs, gastro-entérologie (Private Limited)

Dossier Dr. Nathalie Schoofs, gastro-entérologie, printed on 18 September 2026 from databakkes.be/en/0810119551/dr-nathalie-schoofs-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Nathalie Schoofs, gastro-entérologie from Jodoigne, company number BE0810119551, closed financial year 2024 with a result of € 28,589 after tax. For that financial year Dr. Nathalie Schoofs, gastro-entérologie recorded a gross margin of € 76,402 and equity of € 324,568. Compared with financial year 2023, the result moved from € 30,298 to € 28,589. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.

What it is worth Growing

€ 324,568

▲ 1% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,589

▼ 6% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 63,365

▲ 11% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 23,841 paid out

83 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 8,178

▼ 10% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 18,434

▼ 29% vs 2023

€ 15,177 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 5,956

▲ 8% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 76,985 Gross margin 2021: € 76,985 First fiscal year in the series	€ 68,673 Gross margin 2022: € 68,673 ▼ 11% vs 2021 (€ 76,985) Unfavourable step	€ 62,980 Gross margin 2023: € 62,980 ▼ 8% vs 2022 (€ 68,673) Unfavourable step	€ 76,402 Gross margin 2024: € 76,402 ▲ 21% vs 2023 (€ 62,980) Favourable step	▲ 21%
Profit after taxes	€ 41,450 Profit after taxes 2021: € 41,450 First fiscal year in the series	€ 34,751 Profit after taxes 2022: € 34,751 ▼ 16% vs 2021 (€ 41,450) Unfavourable step	€ 30,298 Profit after taxes 2023: € 30,298 ▼ 13% vs 2022 (€ 34,751) Unfavourable step	€ 28,589 Profit after taxes 2024: € 28,589 ▼ 6% vs 2023 (€ 30,298) Unfavourable step	▼ 6%
Equity	€ 302,538 Equity 2021: € 302,538 First fiscal year in the series	€ 337,289 Equity 2022: € 337,289 ▲ 11% vs 2021 (€ 302,538) Favourable step	€ 319,821 Equity 2023: € 319,821 ▼ 5% vs 2022 (€ 337,289) Unfavourable step	€ 324,568 Equity 2024: € 324,568 ▲ 1% vs 2023 (€ 319,821) Favourable step	▲ 1%
Total debts	€ 98,582 Total debts 2021: € 98,582 First fiscal year in the series	€ 40,228 Total debts 2022: € 40,228 ▼ 59% vs 2021 (€ 98,582) Favourable step	€ 64,518 Total debts 2023: € 64,518 ▲ 60% vs 2022 (€ 40,228) Unfavourable step	€ 52,788 Total debts 2024: € 52,788 ▼ 18% vs 2023 (€ 64,518) Favourable step	▼ 18%
Cash	€ 66,721 Cash 2021: € 66,721 First fiscal year in the series	€ 61,924 Cash 2022: € 61,924 ▼ 7% vs 2021 (€ 66,721) Unfavourable step	€ 56,871 Cash 2023: € 56,871 ▼ 8% vs 2022 (€ 61,924) Unfavourable step	€ 63,365 Cash 2024: € 63,365 ▲ 11% vs 2023 (€ 56,871) Favourable step	▲ 11%
Land & buildings	€ 3,135 Land & buildings 2021: € 3,135 First fiscal year in the series	€ 5,981 Land & buildings 2022: € 5,981 ▲ 91% vs 2021 (€ 3,135) Unchanged	€ 5,264 Land & buildings 2023: € 5,264 ▼ 12% vs 2022 (€ 5,981) Unchanged	€ 4,501 Land & buildings 2024: € 4,501 ▼ 14% vs 2023 (€ 5,264) Unchanged	▼ 14%
Retained profit	€ 195,778 Retained profit 2021: € 195,778 First fiscal year in the series	€ 230,529 Retained profit 2022: € 230,529 ▲ 18% vs 2021 (€ 195,778) Favourable step	€ 213,060 Retained profit 2023: € 213,060 ▼ 8% vs 2022 (€ 230,529) Unfavourable step	€ 217,808 Retained profit 2024: € 217,808 ▲ 2% vs 2023 (€ 213,060) Favourable step	▲ 2%
Dividend	€ 20,573 Dividend 2021: € 20,573 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 20,573) Unchanged	€ 47,767 Dividend 2023: € 47,767 Unchanged (€ 0) Unchanged	€ 23,841 Dividend 2024: € 23,841 ▼ 50% vs 2023 (€ 47,767) Unchanged	▼ 50%
Bank debt	€ 40,089 Bank debt 2021: € 40,089 First fiscal year in the series	€ 33,418 Bank debt 2022: € 33,418 ▼ 17% vs 2021 (€ 40,089) Favourable step	€ 26,026 Bank debt 2023: € 26,026 ▼ 22% vs 2022 (€ 33,418) Favourable step	€ 18,434 Bank debt 2024: € 18,434 ▼ 29% vs 2023 (€ 26,026) Favourable step	▼ 29%
Balance sheet total	€ 401,121 Balance sheet total 2021: € 401,121 First fiscal year in the series	€ 377,517 Balance sheet total 2022: € 377,517 ▼ 6% vs 2021 (€ 401,121) Unchanged	€ 384,339 Balance sheet total 2023: € 384,339 ▲ 2% vs 2022 (€ 377,517) Unchanged	€ 377,356 Balance sheet total 2024: € 377,356 ▼ 2% vs 2023 (€ 384,339) Unchanged	▼ 2%

Key figures of Dr. Nathalie Schoofs, gastro-entérologie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Nathalie Schoofs, gastro-entérologie?

What happened at Dr. Nathalie Schoofs, gastro-entérologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2025 New annual accounts for financial year 2024: profit of € 28,589 (▼ 6% vs 2023). filed late Source: NBB ↗
Feb 24, 2009 Start of the company according to the CBE. KBO

In short

From € 41,450 profit in 2021 to € 28,589 profit in 2024.

Paid € 68,490 in corporate taxes since 2021.

Best year ever: 2021, with € 41,450 profit.

Paid out € 92,182 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Nathalie Schoofs, gastro-entérologie? We notify you, reason included.

Follow Dr. Nathalie Schoofs, gastro-entérologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nathalie Schoofs

Dr. Nathalie Schoofs, gastro-entérologie

Behind Dr. Nathalie Schoofs, gastro-entérologie is Nathalie Schoofs.

See the full network in the app

Directors

According to the 2024 annual accounts

Nathalie Schoofs

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bey Defoer(Jod.) 16

1370 Jodoigne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0810.119.551
VAT number: BE 0810.119.551
Registered office: Rue du Bey Defoer(Jod.) 16, 1370 Jodoigne
Names & denominations: Dr. Nathalie Schoofs, gastro-entérologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 February 2009
Peppol: Active · Active since 17 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗